Mutations of the tumor suppressor gene phosphatase and tensin homologue (PTEN) were found to play a significant role in the pathogenesis of endometrial cancer, with PTEN mutation present in approximately 40–80% of cases3, 4, 5. The gene discussed is PTEN; the disease is endometrial cancer.